	US 12,109,442 B2
	Oral care compositions and methods of use
Wilbens Josias, North Plainfield, NJ (US); Richard Robinson, Belle Mead, NJ (US); Adam Pepperney, Easton, PA (US); and Kimdra Smith-Webster, Williamstown, NJ (US)
Assigned to Colgate-Palmolive Company, New York, NY (US)
Appl. No. 15/539,230
Filed by Colgate-Palmolive Company, New York, NY (US)
PCT Filed Dec. 26, 2014, PCT No. PCT/US2014/072451 § 371(c)(1), (2) Date Jun. 23, 2017, PCT Pub. No. WO2016/105440, PCT Pub. Date Jun. 30, 2016.
Prior Publication US 2017/0348550 A1, Dec. 7, 2017
Int. Cl. A61Q 11/00 (2006.01); A61K 8/19 (2006.01); A61K 8/24 (2006.01); A61K 8/27 (2006.01); A61K 8/34 (2006.01); A61K 8/44 (2006.01); A61K 8/46 (2006.01); A61K 8/49 (2006.01)

CPC A61Q 11/00 (2013.01) [A61K 8/19 (2013.01); A61K 8/24 (2013.01); A61K 8/27 (2013.01); A61K 8/34 (2013.01); A61K 8/44 (2013.01); A61K 8/466 (2013.01); A61K 8/49 (2013.01)]

6 Claims

1. An oral care composition comprising:

arginine, in free or salt form;

a mixture comprising zinc oxide and zinc citrate;

a preservative, wherein the preservative is benzyl alcohol, wherein the benzyl alcohol is in an amount of 0.7% by wt., wherein the arginine is present in an amount of 1% to 15% wt. based on the weight of the oral care composition, the weight of the arginine being calculated as free base form, wherein zinc oxide is present in an amount of 1% wt. based on the weight of the oral care composition, and wherein the zinc citrate is in an amount of from 0.5% wt. based on the weight of the oral care composition; and

wherein the pH of the oral care composition is between 7.5 and 10.5.